Gastric Neuroendocrine Carcinomas in Bearded Dragons (Pogona vitticeps)
Authors:
Open Access
- 15 July 2009
- journal article
- research article
- Published by SAGE Publications in Veterinary Pathology
- Vol. 46 (6) , 1109-1116
Abstract
This article describes a newly recognized highly malignant neoplastic entity in young bearded dragons ( Pogona vitticeps), gastric neuroendocrine carcinomas, which readily metastasize. Ten bearded dragons with histories of anorexia (8), vomiting (3), hyperglycemia (2), and anemia (3) were included in this study. All animals had neoplastic masses in their stomach, with metastasis to the liver. Microscopically, 6 of these neuroendocrine carcinomas were well-differentiated and 4 were poorly differentiated. For further characterization, immunohistochemistry for protein gene product 9.5, neuron-specific enolase, endorphin, chromogranins A and B, synaptophysin, somatostatin, insulin, glucagon, gastrin, pancreatic polypeptide, and vasoactive intestinal peptide was performed on 5 animals. Because only immunolabeling for somatostatin was consistently observed in all neoplasms, a diagnosis of somatostatinoma was made for these 5 bearded dragons. Some neoplasms also exhibited multihormonal expression. Electron microscopy performed on 1 tumor confirmed the presence of neuroendocrine granules within neoplastic cells. Gastric neuroendocrine carcinomas, and specifically somatostatinomas, have not been previously reported in bearded dragons, or other reptiles, and may be underdiagnosed due to inconsistent, ambiguous clinical signs. In humans, pancreatic somatostatinomas are associated with a syndrome of hypersomatostatinemia, which includes hyperglycemia, weight loss, and anemia, as observed in some of these bearded dragons. Somatostatinomas in humans are commonly associated with neurofibromatosis type 1 (Von Recklinghausen's disease), caused by a mutation in the tumor suppressor gene NF1, which results in decreased expression of neurofibromin. In all 5 animals examined, neoplasms exhibited decreased neurofibromin expression compared with control tissues, suggesting that decreased functional neurofibromin may play a role in the pathogenesis of somatostatinomas in bearded dragons.Keywords
This publication has 20 references indexed in Scilit:
- Pancreatic Endocrine Tumors are a Rare Manifestation of the Neurofibromatosis Type 1 PhenotypeAmerican Journal of Surgical Pathology, 2006
- Multicentric Benign Peripheral Nerve Sheath Tumors in Two Related Bearded Dragons, Pogona vitticepsVeterinary Pathology, 2005
- Reptile neoplasia: a retrospective study of case submissions to a specialty diagnostic serviceVeterinary Clinics of North America: Exotic Animal Practice, 2004
- The Chromogranin–Secretogranin FamilyNew England Journal of Medicine, 2003
- Neurofibromin, a Tumor Suppressor in the Nervous SystemExperimental Cell Research, 2001
- Von recklinghausen's disease associated with duodenal somatostatinoma: Contrast of duodenal versus pancreatic somatostatinomasJournal of Surgical Oncology, 1995
- Neurofibromatosis type 1European Journal of Cancer, 1994
- An histological and immunocytochemical study of the neuroendocrine cells in the intestine of Podarcis hispanica Steindachner, 1870 (Lacertidae)Cell and tissue research, 1991
- Histological and immunocytochemical study of the endocrine pancreas of the lizard Podarcis hispanica steindachner, 1870 (lacertidae)General and Comparative Endocrinology, 1988
- THE CLASSIFICATION OF CARCINOID TUMOURSThe Lancet, 1963